12:00 AM
Nov 25, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Danegaptide: Phase II started

Zealand began a double-blind, placebo-controlled, Danish Phase II trial to evaluate 2 doses of danegaptide in combination with balloon dilatation in >=600 patients....

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >